• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 D1 可解除 HDAC4 和 5 对 TBX5 的抑制作用。

HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1.

机构信息

School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.

出版信息

Sci Rep. 2019 Nov 29;9(1):17992. doi: 10.1038/s41598-019-54312-w.

DOI:10.1038/s41598-019-54312-w
PMID:31784580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6884511/
Abstract

TBX5 is a T-box family transcription factor that regulates heart and forelimb development in vertebrates and functional deficiencies in this protein result in Holt-Oram syndrome. Recently, we have shown that acetylation of TBX5 potentiates its activity and is important for heart and limb development. Here we report that class II histone deacetylases HDAC4 and HDAC5 associate with TBX5 and repress its role in cardiac gene transcription. Both HDAC4 and HDAC5 deacetylate TBX5, which promotes its relocation to the cytoplasm and HDAC4 antagonizes the physical association and functional cooperation between TBX5 and MEF2C. We also show that protein kinase D1 (PRKD1) relieves the HDAC4/5-mediated repression of TBX5. Thus, this study reveals a novel interaction of HDAC4/5 and PRKD1 in the regulation of TBX5 transcriptional activity.

摘要

TBX5 是 T 盒家族转录因子,在脊椎动物中调节心脏和前肢发育,该蛋白的功能缺失会导致 Holt-Oram 综合征。最近,我们已经证明 TBX5 的乙酰化可以增强其活性,对心脏和肢体发育很重要。在这里,我们报告说,II 类组蛋白去乙酰化酶 HDAC4 和 HDAC5 与 TBX5 结合,并抑制其在心脏基因转录中的作用。HDAC4 和 HDAC5 都使 TBX5 去乙酰化,这促进了 TBX5 向细胞质的重新定位,HDAC4 拮抗 TBX5 与 MEF2C 之间的物理关联和功能合作。我们还表明,蛋白激酶 D1(PRKD1)缓解了 HDAC4/5 对 TBX5 的抑制作用。因此,本研究揭示了 HDAC4/5 和 PRKD1 在调节 TBX5 转录活性中的新相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/ecee37af8703/41598_2019_54312_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/4488081e7deb/41598_2019_54312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/99b4c370a55d/41598_2019_54312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/002ae6d47f39/41598_2019_54312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/b2400fa1a2cb/41598_2019_54312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/06a6a90dd594/41598_2019_54312_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/ecee37af8703/41598_2019_54312_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/4488081e7deb/41598_2019_54312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/99b4c370a55d/41598_2019_54312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/002ae6d47f39/41598_2019_54312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/b2400fa1a2cb/41598_2019_54312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/06a6a90dd594/41598_2019_54312_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e89/6884511/ecee37af8703/41598_2019_54312_Fig6_HTML.jpg

相似文献

1
HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1.蛋白激酶 D1 可解除 HDAC4 和 5 对 TBX5 的抑制作用。
Sci Rep. 2019 Nov 29;9(1):17992. doi: 10.1038/s41598-019-54312-w.
2
KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.KLF13是 Holt-Oram综合征基因TBX5的遗传修饰因子。
Hum Mol Genet. 2017 Mar 1;26(5):942-954. doi: 10.1093/hmg/ddx009.
3
Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.在具有不同临床表现的 Holt-Oram 综合征患者中,两种新型 TBX5 变异体的功能分析。
Mol Genet Genomics. 2021 Jul;296(4):809-821. doi: 10.1007/s00438-021-01781-2. Epub 2021 Apr 17.
4
[Holt-Oram syndrome: family affected without TBX5 mutation and without phenotype manifestations in a probable mutation carrier].[ Holt-Oram综合征:一个家族中存在未携带TBX5突变且无表型表现的可能突变携带者 ]
Rev Esp Cardiol. 2011 Dec;64(12):1225-6. doi: 10.1016/j.recesp.2011.02.016. Epub 2011 Jul 12.
5
Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications.由TBX5基因错义突变、延伸蛋白突变以及TBX5基因内重复导致的 Holt-Oram综合征临床特征的分子基础
Gene. 2015 Apr 15;560(2):129-36. doi: 10.1016/j.gene.2015.02.017. Epub 2015 Feb 11.
6
Tbx5 inhibits hedgehog signaling in determination of digit identity.Tbx5 抑制 Hedgehog 信号在指数字身份确定中的作用。
Hum Mol Genet. 2020 Jun 3;29(9):1405-1416. doi: 10.1093/hmg/ddz185.
7
Familial dilated cardiomyopathy associated with pathogenic TBX5 variants: Expanding the cardiac phenotype associated with Holt-Oram syndrome.与致病性 TBX5 变异相关的家族性扩张型心肌病:扩展与 Holt-Oram 综合征相关的心脏表型。
Am J Med Genet A. 2020 Jul;182(7):1725-1734. doi: 10.1002/ajmg.a.61635. Epub 2020 May 25.
8
TBX3 and TBX5 duplication: A family with an atypical overlapping Holt-Oram/ulnar-mammary syndrome phenotype.TBX3 和 TBX5 基因重复:具有非典型重叠 Holt-Oram/尺骨-乳房综合征表型的一家系。
Eur J Med Genet. 2021 Jul;64(7):104213. doi: 10.1016/j.ejmg.2021.104213. Epub 2021 Apr 27.
9
Exome sequencing identifies a c.148-1G>C mutation of TBX5 in a Holt-Oram family with unusual genotype-phenotype correlations.外显子组测序在一个具有不寻常基因型-表型相关性的霍尔特-奥勒姆综合征家系中鉴定出TBX5基因的c.148-1G>C突变。
Cell Physiol Biochem. 2015;37(3):1066-74. doi: 10.1159/000430232. Epub 2015 Sep 25.
10
MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome.微小RNA 19a替代疗法可部分挽救斑马鱼霍尔特-奥拉姆综合征模型中的鳍和心脏缺陷。
Sci Rep. 2015 Dec 14;5:18240. doi: 10.1038/srep18240.

引用本文的文献

1
Single-nuclei multiomics analysis identifies abnormal cardiomyocytes in a murine model of cardiac development.单核多组学分析在心脏发育小鼠模型中鉴定出异常心肌细胞。
Nat Commun. 2025 Jul 29;16(1):6947. doi: 10.1038/s41467-025-62208-9.
2
PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.PPM1G通过催化TET1去磷酸化使其不稳定,从而损害其对CLDN3启动子的靶向去甲基化,抑制胆管癌中的上皮-间质转化。
Adv Sci (Weinh). 2024 Dec;11(47):e2407323. doi: 10.1002/advs.202407323. Epub 2024 Oct 30.
3

本文引用的文献

1
Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development.TBX5 的乙酰化由 KAT2B 和 KAT2A 调控,调节心脏和肢体发育。
J Mol Cell Cardiol. 2018 Jan;114:185-198. doi: 10.1016/j.yjmcc.2017.11.013. Epub 2017 Nov 22.
2
The Cardiac TBX5 Interactome Reveals a Chromatin Remodeling Network Essential for Cardiac Septation.心脏TBX5相互作用组揭示了心脏分隔所必需的染色质重塑网络。
Dev Cell. 2016 Feb 8;36(3):262-75. doi: 10.1016/j.devcel.2016.01.009.
3
Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
Context-dependent T-BOX transcription factor family: from biology to targeted therapy.
上下文相关的 T-BOX 转录因子家族:从生物学到靶向治疗。
Cell Commun Signal. 2024 Jul 4;22(1):350. doi: 10.1186/s12964-024-01719-2.
4
Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart.PRKD1 蛋白激酶缺失对小鼠胚胎心脏发育的影响。
J Anat. 2024 Jul;245(1):70-83. doi: 10.1111/joa.14033. Epub 2024 Feb 28.
5
HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma.组蛋白去乙酰化酶 5 调节 SATB1 转录活性以促进肺腺癌。
Br J Cancer. 2023 Sep;129(4):586-600. doi: 10.1038/s41416-023-02341-8. Epub 2023 Jul 3.
6
Cardiac Acetylation in Metabolic Diseases.代谢性疾病中的心脏乙酰化作用
Biomedicines. 2022 Jul 29;10(8):1834. doi: 10.3390/biomedicines10081834.
7
The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications.SUMOylation 的功能及其在心血管疾病中的关键作用和潜在的临床意义。
Int J Mol Sci. 2021 Sep 30;22(19):10618. doi: 10.3390/ijms221910618.
8
A zebrafish forward genetic screen identifies an indispensable threonine residue in the kinase domain of PRKD2.一项斑马鱼正向遗传学筛选发现了 PRKD2 激酶结构域中一个不可或缺的苏氨酸残基。
Biol Open. 2021 Mar 9;10(3):bio058542. doi: 10.1242/bio.058542.
小泛素样修饰物(SUMO)结合及信号转导与转录激活因子1的蛋白抑制剂(PIAS1)对Tbx5介导的反式激活作用的增强
Int J Biochem Cell Biol. 2014 May;50:82-92. doi: 10.1016/j.biocel.2014.02.007. Epub 2014 Feb 26.
4
Signaling and transcriptional networks in heart development and regeneration.心脏发育和再生中的信号转导和转录网络。
Cold Spring Harb Perspect Biol. 2013 Mar 1;5(3):a008292. doi: 10.1101/cshperspect.a008292.
5
Synergistic activation of cardiac genes by myocardin and Tbx5.心肌调节蛋白和 Tbx5 协同激活心脏基因。
PLoS One. 2011;6(8):e24242. doi: 10.1371/journal.pone.0024242. Epub 2011 Aug 29.
6
Physical interaction between TBX5 and MEF2C is required for early heart development.TBX5与MEF2C之间的物理相互作用是早期心脏发育所必需的。
Mol Cell Biol. 2009 Apr;29(8):2205-18. doi: 10.1128/MCB.01923-08. Epub 2009 Feb 9.
7
The many roles of histone deacetylases in development and physiology: implications for disease and therapy.组蛋白去乙酰化酶在发育和生理学中的多种作用:对疾病和治疗的影响。
Nat Rev Genet. 2009 Jan;10(1):32-42. doi: 10.1038/nrg2485.
8
Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice.组蛋白去乙酰化酶3对小鼠心脏能量代谢的维持作用
J Clin Invest. 2008 Nov;118(11):3588-97. doi: 10.1172/JCI35847. Epub 2008 Oct 1.
9
Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.心脏中Hdac3的转基因过表达会使出生后心肌细胞增殖增加,但不会诱发肥大。
J Biol Chem. 2008 Sep 26;283(39):26484-9. doi: 10.1074/jbc.M803686200. Epub 2008 Jul 14.
10
Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.蛋白激酶D依赖性的组蛋白去乙酰化酶5磷酸化及核输出介导血管内皮生长因子诱导的基因表达和血管生成。
J Biol Chem. 2008 May 23;283(21):14590-9. doi: 10.1074/jbc.M800264200. Epub 2008 Mar 10.